Tania Ahuja

✅ out our review on the latest on the management of pulmonary embolism!
🫁 🩸 💉 💊

pmc.ncbi.nlm.nih.gov/articles/PMC...

The always impeccably dressed Samuel Bernard presenting #TEE in #cardiacarrest @umn-ccces.bsky.social. Is it too early or too late? @jameshorowitzmd.bsky.social @bkatli.bsky.social @taniaahuja.bsky.social #umnccces25 #cardiosky #cccsky

PHARMACICU: Past, Present, and Future of the Pharmacist in the Cardiac Intensive Care Unit

✅ out our 📄 on the past, present and future of cardiac intensive care unit pharmacists!
💊 🫀 🫶🏼
@jaccjournals.bsky.social

www.jacc.org/doi/abs/10.1...

at DOM research day!
(also, LGK! 🧡💙)

Fantastic session at #ACC25! Thank you @amandagarfinkel.bsky.social for addressing the emotional challenges of bad outcomes. Phenomenal panelists JasonKatzMD AnnGageMD @withheartdrmelanie.bsky.social & Dr. Landzberg sharing experiences and advice! @accintouch.bsky.social #CardioSky

Big thanks to my amazing panelists for an insightful discussion #ACC25! Your expertise and perspectives made it a truly great session! Grateful for the conversation and amazing audience! @accintouch.bsky.social @taniaahuja.bsky.social
(📸 courtesy of @jameshorowitzmd.bsky.social) #cardiosky

Check out 👀 this poster from @nyu.edu @taniaahuja.bsky.social on balancing drug-drug interactions between antiplatelet and antiretroviral therapy at #ACC25. Learn more about this important intersection of cardiovascular and HIV care on Sunday, March 30. @accintouch.bsky.social

Almost time #Chicago! Proud to have helped organize From a Spark to a Flame for #ACC25! A dynamic panel on cultivating unique interests and passions in your career. Join us Saturday, March 29 at 4:00 PM CDT at #ACC25 for expert insights. #CardioSky @accintouch.bsky.social @taniaahuja.bsky.social

watching #ThePitt and not one, but BOTH STEMIs, with & without ECMO, were loaded with chewable ASA 324 mg but 👏 no 👏 P2Y12inh 👏

love to see it 🫀 🫶🏼❤️‍🩹

are you at #SCCM2025 ?
come check out a presentation on the role of quinidine in the cardiac ICU from @nyulangone.bsky.social pharmacy PGY2 in critical care on Sunday 2/23 at 2:30!
@sccmcriticalcare.bsky.social @sccmjournals.bsky.social

abstract ➡️ journals.lww.com/ccmjournal/f...

We were featured! 🌟

journals.lww.com/cardiovascul...

150mg IV bolus, then 1mg/min for 6 hr, then 0.5mg/min for 18hr & transition to PO with bid or tid at end of this.
If awaiting ablation, or rates still > 110, may leave on IV longer at the 0.5.
For VT, or atrial in CICU we will leave at 1mg/min for longer, usually drop to 0.5 on day 2 or 3.

Hmm we rarely overlap, but if critically ill, in 💔 shock we use IV for > 1 day & likely saturate distribution. Plasma levels seem to not correlate with efficacy or toxicity, given distribution. We begin PO w/load (400 bid or tid) soon as IV completes to get to 5-10gm depending on arrhythmia.

Abstract

do you use valproic acid In your ICUs to manage hyperactive delirium or agitation?

✅ out our experience ⬇️

journals.sagepub.com/doi/10.1177/...

What's the optimal timing of P2Y12 inhibitor for NSTEMI? ⏰

🫀In modern NSTEMI management, P2Y12 inhibitor before PCI is unnecessary

@jaccjournals.bsky.social @ahascience.bsky.social

#AHA24

www.jacc.org/doi/10.1016/...

https://journals.lww.com/cardiovascularpharm/abstract/9900/digoxin_loading_doses_and_serum_digoxin.391.aspx

check out our 📄 on digoxin loading doses for treatment of atrial arrhythmias in critically ill patients 🫀💛🫀

journals.lww.com/cardiovascul...

@jameshorowitzmd.bsky.social

Hypochloremia is associated with diuretic resistance. In 👇 study from Yale, hypochloremia was associated with poor diuretic efficiency (defined as mmol of UNa per doubling of loop diuretic dose). Of note - serum sodium was NOT associated with diuretic efficiency #cardiosky

Congratulations to @johnlsapp on the presentation and publication of VANISH-2.

First line VT ablation is associated with significant reduction in composite of death, VT, storm for patients with ischemic cardiomyopathy.

www.nejm.org/doi/full/10....

https://journals.lww.com/cardiovascularpharm/abstract/9900/balancing_the_interactions__assessing_antiplatelet.387.aspx

Check out our paper on DDI with antiretrovirals and antiplatelets 💊🫀

we found high incidence but unclear how much this correlates with MACE or 🩸

journals.lww.com/cardiovascul...